These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

814 related items for PubMed ID: 16083522

  • 1. Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.
    Griessinger N, Sittl R, Likar R.
    Curr Med Res Opin; 2005 Aug; 21(8):1147-56. PubMed ID: 16083522
    [Abstract] [Full Text] [Related]

  • 2. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R, Lorenz V, Korak-Leiter M, Kager I, Sittl R.
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [Abstract] [Full Text] [Related]

  • 3. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
    Likar R, Kayser H, Sittl R.
    Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study.
    Muriel C, Failde I, Micó JA, Neira M, Sánchez-Magro I.
    Clin Ther; 2005 Apr; 27(4):451-62. PubMed ID: 15922818
    [Abstract] [Full Text] [Related]

  • 5. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.
    Pain Pract; 2008 Apr; 8(4):287-313. PubMed ID: 18503626
    [Abstract] [Full Text] [Related]

  • 6. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
    Sorge J, Sittl R.
    Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
    [Abstract] [Full Text] [Related]

  • 7. [Post marketing surveillance study with an analgesic (transdermal buprenorphine patch) in patients with moderate to severe chronic pain].
    Tschirner M, Ritzdorf I, Brünjes R.
    MMW Fortschr Med; 2008 Sep 18; 150 Suppl 3():142-8. PubMed ID: 19025217
    [Abstract] [Full Text] [Related]

  • 8. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
    Landau CJ, Carr WD, Razzetti AJ, Sessler NE, Munera C, Ripa SR.
    Clin Ther; 2007 Oct 18; 29(10):2179-93. PubMed ID: 18042474
    [Abstract] [Full Text] [Related]

  • 9. Opioid rotation from high-dose morphine to transdermal buprenorphine (Transtec) in chronic pain patients.
    Freye E, Anderson-Hillemacher A, Ritzdorf I, Levy JV.
    Pain Pract; 2007 Jun 18; 7(2):123-9. PubMed ID: 17559481
    [Abstract] [Full Text] [Related]

  • 10. Transdermal buprenorphine in cancer pain and palliative care.
    Sittl R.
    Palliat Med; 2006 Jun 18; 20 Suppl 1():s25-30. PubMed ID: 16764218
    [Abstract] [Full Text] [Related]

  • 11. Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational study.
    Mercadante S, Porzio G, Ferrera P, Aielli F, Verna L, Tirelli W, Villari P, Casuccio A.
    Clin Ther; 2009 Oct 18; 31(10):2134-8. PubMed ID: 19922884
    [Abstract] [Full Text] [Related]

  • 12. Transdermal buprenorphine for the treatment of moderate to severe chronic pain: results from a large multicenter, non-interventional post-marketing study in Poland.
    Przeklasa-Muszynska A, Dobrogowski J.
    Curr Med Res Opin; 2011 Jun 18; 27(6):1109-17. PubMed ID: 21456888
    [Abstract] [Full Text] [Related]

  • 13. Transdermal buprenorphine in the treatment of chronic pain.
    Sittl R.
    Expert Rev Neurother; 2005 May 18; 5(3):315-23. PubMed ID: 15938664
    [Abstract] [Full Text] [Related]

  • 14. The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus.
    Pergolizzi JV, Mercadante S, Echaburu AV, Van den Eynden B, Fragoso RM, Mordarski S, Lybaert W, Beniak J, Orońska A, Slama O, Euromed Communications meeting.
    Curr Med Res Opin; 2009 Jun 18; 25(6):1517-28. PubMed ID: 19435402
    [Abstract] [Full Text] [Related]

  • 15. Buprenorphine TDS: use in daily practice, benefits for patients.
    Radbruch L.
    Int J Clin Pract Suppl; 2003 Feb 18; (133):19-22; discussion 23-4. PubMed ID: 12665120
    [Abstract] [Full Text] [Related]

  • 16. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
    Sittl R, Nuijten M, Nautrup BP.
    Clin Ther; 2005 Jul 18; 27(7):1022-31. PubMed ID: 16154481
    [Abstract] [Full Text] [Related]

  • 17. Effects of transdermal buprenorphine on patients-reported outcomes in cancer patients: results from the Cancer Pain Outcome Research (CPOR) Study Group.
    Apolone G, Corli O, Negri E, Mangano S, Montanari M, Greco MT, Cancer Pain Outcome Research Study Group (CPOR SG) Investigators, Apolone G, Bertetto O, Caraceni A, Corli O, De Conno F, Labianca R, Maltoni M, Nicora Maria F, Torri V, Zucco F.
    Clin J Pain; 2009 Oct 18; 25(8):671-82. PubMed ID: 19920716
    [Abstract] [Full Text] [Related]

  • 18. High dose transdermal buprenorphine for moderate to severe pain in spanish pain centres--a retrospective multicenter safety and efficacy study.
    Barutell C, Camba A, González-Escalada JR, Rodríguez M, Opioid Group of the Spanish Society for the Study of Pain.
    Pain Pract; 2008 Oct 18; 8(5):355-61. PubMed ID: 18662364
    [Abstract] [Full Text] [Related]

  • 19. Transdermal buprenorphine in pain management--experiences from clinical practice: Five case studies.
    Louis F.
    Int J Clin Pract; 2006 Oct 18; 60(10):1330-4. PubMed ID: 16981980
    [Abstract] [Full Text] [Related]

  • 20. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
    Sittl R, Likar R, Nautrup BP.
    Clin Ther; 2005 Feb 18; 27(2):225-37. PubMed ID: 15811486
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.